Lazard Asset Management’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
Other funds holding MRVI
1WCM
Lazard Asset Management's MRVI Position: Q3 2026 in Review
Lazard Asset Management sold out of Maravai LifeSciences (MRVI) in Q3 2026, closing a stake of 420,360 shares — an estimated $2.62M sold.
Lazard Asset Management first reported a position in MRVI in Q4 2020 and held it in 23 quarters. The position peaked at $120M in Q1 2021. 202 funds tracked by Wall St. Rank hold MRVI as of Q3 2026.
- Lazard Asset Management reported no remaining Maravai LifeSciences position as of Q3 2026 after selling out during the quarter.
- Lazard Asset Management sold 420,360 Maravai LifeSciences shares in Q3 2026, an estimated $2.62M.
- Lazard Asset Management first reported a position in Maravai LifeSciences in Q4 2020 and held it in 23 quarters.
- Lazard Asset Management's Maravai LifeSciences position peaked at $120M in Q1 2021.
- 202 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2026.
Based on Lazard Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.